Inhalon Biopharma
San Diego, United States· Est. 2016
Inhalon Biopharma is a clinical-stage biotechnology company with a precedent-setting inhaled drug platform for treating patients suffering from acute respiratory infections.
Private Company
Total funding raised: $37M
About
Inhalon Biopharma is a clinical-stage biotechnology company with a precedent-setting inhaled drug platform for treating patients suffering from acute respiratory infections.
Biologics
Funding History
2Total raised:$37M
Series A$32MMar 15, 2022
Seed$5MSep 15, 2020